Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMay 24, 2017PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0734-2017Class IITerminatedMay 24, 2017PGE1/CPZ 5ML MDV 20MCG/1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0733-2017Class IITerminatedMay 24, 2017PGE1 5ML MDV INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0732-2017Class IITerminatedMay 24, 2017PGE1 MDV 20MCG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0731-2017Class IITerminatedMay 24, 2017PAPAVERINE/PHENT 5ML MDV 30/1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0730-2017Class IITerminatedMay 24, 2017PAPAVERINE/PHENT 5ML MDV 30/0.5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0729-2017Class IITerminatedMay 24, 2017HYDROXO-B12 5ML PBF MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0728-2017Class IITerminatedMay 24, 2017HYDROXO-B12 PBF MDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0727-2017Class IITerminatedMay 24, 2017HYDROXO-B12 30ML PBF MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0726-2017Class IITerminatedMay 24, 2017HYDROXO-B12 5ML PBF MDV 1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0725-2017Class IITerminatedMay 24, 2017HYDROXO-B12 10ML PBF MDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0724-2017Class IITerminatedMay 24, 2017HYDROXO-B12 INH PF GV 5MG/ML SOLNLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0723-2017Class IITerminatedMay 24, 2017HYDROXO-B12 1ML SDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0722-2017Class IITerminatedMay 24, 2017HYDROXO-B12 *1ML* SDV 1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0721-2017Class IITerminatedMay 24, 2017HCG *10ML* MDV 500U/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0720-2017Class IITerminatedMay 24, 2017FOLINIC ACID MDV INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0719-2017Class IITerminatedMay 24, 2017FOLINIC ACID MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0718-2017Class IITerminatedMay 24, 2017FOLIC ACID 1ML SDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0717-2017Class IITerminatedMay 24, 2017FERR GLUC/PROCAINE 10ML MDV 60/10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0716-2017Class IITerminatedMay 24, 2017DMSO 6.25% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0715-2017Class IITerminatedMay 24, 2017DMPS ACID *5ML* SDV 50MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0714-2017Class IITerminatedMay 24, 2017CO-Q-10 OIL 20ML MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0713-2017Class IITerminatedMay 24, 2017ATROPINE SULFATE 0.5% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0712-2017Class IITerminatedMay 24, 2017ATROPINE SULFATE 0.01% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0711-2017Class IITerminatedMay 24, 20175-MTHF SDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0710-2017Class IITerminatedMay 24, 20175-MTHF 10ML SDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0709-2017Class IITerminatedMay 24, 20175-MTHF 10ML MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0708-2017Class IITerminatedMay 24, 20175-MTHF *10ML* MDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0707-2017Class IITerminatedMay 17, 2017Clozapine Tablets USPMicrobial Contamination of Non-Sterile ProductsTeva Pharmaceuticals USA · D-0705-2017Class IIITerminatedMay 17, 2017MozobilLabeling: Incorrect or Missing Package InsertSanofi-Aventis U.S. LLC · D-0704-2017Class IIITerminatedMay 17, 2017PrednisoLONE Oral Solution USPFailed Stability SpecificationsTeva Pharmaceuticals USA · D-0703-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0702-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0701-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0700-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0699-2017Class IITerminatedMay 17, 2017Buprenorphine HCI InjectionCrystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose...PAR Sterile Products LLC · D-0698-2017Class IIITerminatedMay 17, 2017IC-GreenProduct is being recalled due to low pH value.Akorn, Inc. · D-0697-2017Class IITerminatedMay 10, 2017Sulfamethoxazole and Trimethoprim Oral SuspensionFailed Dissolution SpecificationsAkorn Inc · D-0696-2017Class IIITerminatedMay 10, 2017Zinc Oxide Paste 25%Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.Fagron, Inc · D-0695-2017Class IIITerminatedMay 10, 2017Allergy Relief Diphenhydramine HCl 25 mgSubpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.P & L Development, LLC · D-0694-2017

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.